Researchers have found that a genetic mutation seen in about half of all brain tumors produces a response that prevents radiation treatment from working. Altering that response using FDA-approved drugs restores tumors' sensitivity to radiation therapy, extending survival in mice. The paper, representing more than five years of research, is published in Science Translational Medicine.
"These findings have great potential to impact medical treatment of patients with low-grade glioma, which is critically needed for this terrible disease," says senior author.
The IDH1 gene is mutated in about half of gliomas, the most common type of brain cancer. These tumors tend to be low-grade and occur at a younger age. Survival can be seven to 10 years.
"The challenge is that following initial treatment with surgery and chemotherapy, the tumors always come back, and they come back with a vengeance," the senior author says. "If we can intervene early in this diagnosis, before the tumor comes back more aggressive and deadly, it could have a big impact for these patients."
The researchers created a mouse model of IDH1-mutant glioma. The IDH1 mutation does not in itself cause cancer. For a tumor to form, mutations must occur in IDH1, p53 and ATRX.
The researchers discovered that when all three mutations are present, mutated IDH1 increases the tumor cells' DNA damage response. This reduces the efficacy of the radiation treatment, as the cancer cells can now correct the radiation-induced DNA damage.
Adding a drug that inhibits a critical pathway in DNA damage repair made the tumors sensitive to radiation treatment. Researchers initially discovered this using the newly created mutant IDH1 mouse models and confirmed their findings in tissue samples from patients with IDH1-mutant glioma. This suggests that a precision medicine approach to gliomas would better direct their treatment.
The FDA has already approved DNA repair blockers to enhance sensitivity to chemotherapy or radiation in some cancers. The researchers are currently working with colleagues in radiation oncology, pathology, neuro-oncology and neurosurgery to translate their findings into a clinical trial to test the combination in patients with low-grade gliomas with IDH1 mutation.
Pathologists already test for IDH1 mutation as part of the diagnostic process because it influences prognosis and treatment, so this therapeutic strategy would be straightforward to implement in clinic.
"Now we have a potential new way of treating these tumors, that will make radiation deliver a much bigger impact," says lead study author. "By combining these two approaches, we hope that the new treatment will extend remission in these patients and potentially turn low-grade glioma into a chronic disease."
https://labblog.uofmhealth.org/lab-report/tackling-tumors-always-come-back-new-brain-cancer-research-could-improve-outcomes
http://stm.sciencemag.org/content/11/479/eaaq1427
Latest News
Metabolic rewiring promotes…
By newseditor
Posted 18 Apr
A drug to prevent flu-induc…
By newseditor
Posted 18 Apr
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Other Top Stories
Perfusion brain imaging technology saves more stroke victims
Read more
Sour taste buds and inner ear have similar ion channels
Read more
Your brain reveals who your friends are
Read more
A new type of Botox discovered
Read more
Neighboring gene mutation causes epigenetic alternations in vitamin…
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
How does the microbiota con…
By newseditor
Posted 18 Apr
The integrated stress respo…
By newseditor
Posted 18 Apr
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar